PCP's pharmacological action involves antagonism of NMDA receptors, thereby affecting which neurotransmitter system?

Prepare for the Drugs and Human Behavior Test. Study with flashcards and multiple choice questions. Each question includes hints and detailed explanations, ensuring you're ready to excel in your exam!

Multiple Choice

PCP's pharmacological action involves antagonism of NMDA receptors, thereby affecting which neurotransmitter system?

Explanation:
NMDA receptors are ion channels that respond to glutamate, the brain’s main excitatory neurotransmitter. PCP blocks these receptors, acting as a noncompetitive antagonist, so glutamate can’t activate the NMDA receptor channel. This directly dampens glutamatergic signaling, making the glutamate system the one most affected. While PCP can have downstream effects on other systems (like dopamine in certain circuits), the primary neurotransmitter system tied to this action is glutamate.

NMDA receptors are ion channels that respond to glutamate, the brain’s main excitatory neurotransmitter. PCP blocks these receptors, acting as a noncompetitive antagonist, so glutamate can’t activate the NMDA receptor channel. This directly dampens glutamatergic signaling, making the glutamate system the one most affected. While PCP can have downstream effects on other systems (like dopamine in certain circuits), the primary neurotransmitter system tied to this action is glutamate.

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy